Spontaneous expression of mRNA for IL-10, GM-CSF, TGF-β, TNF-α, and IL-6 in peripheral blood mononuclear cells from atopic dermatitis

Annals of Allergy, Asthma and Immunology

Volumn 84, Issue 5, 2000, Pages 553-558

  Lee, Hyun Jeong ^a   Lee, Ho Pyo ^a   Ha, Seog Jun ^b   Byun, Dae Gyoo ^a   Kim, Jin Wou ^a  

^a The Catholic University of Korea   (South Korea)

^b Headquarter of Navy Education   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOREGULATION; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0034041563     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62522-7     Document Type: Article

References (47)

1. Chan SC, Kim JW, Henderson WR, Hanifin JM. Altered prostaglandin E2 regulation of cytokine production in atopic dermatitis. J Immunol 1993; 151:3345-3352.
2. Ohmen JD, Hanifin JM, Nickoloff BJ, et al. Overexpression of IL-10 in atopic dermatitis: contrasting cytokine patterns with delayed-type hypersensitivity reactions. J Immunol 1995;154: 1956-1963.
3. Bratton DL, Hamid Q, Boguniewicz M, et al. Granulocyte macrophage colony-stimulating factor contributes to enhanced monocyte survival in chronic atopic dermatitis. J Clin Invest 1995;95:211-218.
4. Wierenga EA, Snoek M, Jansen HM, et al. Human atopen-specific types 1 and 2 T helper cell clones. J Immunol 1991;147:2942-2949.
5. Parronchi P, Macchia D, Piccini MP, et al. Allergen-bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production. Proc Natl Acad Sci USA 1991;88:4538-4543.
6. + allergen-specific T lymphocytes in atopic dermatitis lesional skin. J Invest Dermatol 1991;97:389-394.
7. Yssel H, Johnson KE, Schneider PV, et al. T cell activation-inducing epitopes of the house dust mite allergen Der pI. J Immunol 1992;148: 738-745.
8. H2 phenotype in patients with atopic dermatitis. J Allergy Clin Immunol 1992;90:184-193.
9. Wierenga EA, Snoek M, Bos JD, et al. Comparison of diversity and function of house dust mite-specific T-lymphocyte clones from atopic and nonatopic donors. J Immunol 1990;20:1519-1526.
10. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol 1980;92:44-48.
11. Esnault S, Benbernou N, Lavaud F, et al. Differential spontaneous expression of mRNA for IL-4, IL-10, IL-13, IL-2 and interferon-gamma (IFN-γ) in peripheral blood mononuclear cells (PBMC) from atopic patients. Clin Exp Immunol 1996;103:111-118.
12. Rousset F, Garcia E, DeFrance T, et al. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA 1992;89:1890-1893.
13. Thompson-Snipes L, Dhar V, Bond MW, et al. Interleukin 10: a novel stimulatory factor for mast cells and their progenitors. J Exp Med 1991; 173:507-510.
14. Friedmann PS, Rees J, Matthews JN. Contact sensitivity to dinitrochlorobenzene is impaired in atopic subjects: controversy revisited. Arch Dermatol 1990;126:1173-1175.
15. Sieling PA, Abrams JS, Yamamura M, et al. Immunosuppressive roles for interleukin-10 and interleukin-4 in human infection: in vitro modulation of T cell responses in leprosy. J Immunol 1993;150:5501-5510.
16. Armstrong L, Jordan N, Miller A. Interleukin 10 (IL-10) regulation of tumor necrosis factor alpha (TNF-alpha) from human alveolar macrophages and peripheral blood monocytes. Thorax 1996;51:143-149.
17. Lopez AF, Williamson DJ, Gamble JR, et al. Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival. J Clin Invest 1986;78: 1220-1228.
18. 4 generation by colony-stimulating factor. Am Rev Respir Dis 1989;140: 1340-1347.
19. Burke LA, Hallsworth MP, Litchfield TM, et al. Identification of the major activity derived from cultured human peripheral blood mononuclear cells, which enhances eosinophil viability, as granulocyte macrophage colony-stimulating factor (GM-CSF). J Allergy Clin Immunol 1991;88:226-235.
20. 2, and mononuclear cell factor production by U937 cells. Cell Immunol 1986;97:286-296.
21. Polla BS, Ezekowitz RA, Leung DYM. Monocytes from patients with atopic dermatitis are primed for superoxide production. J Allergy Clin Immunol 1992;89:545-551.
22. Williams J, Johnson S, Mascali JJ, et al. Regulation of low affinity IgE receptor (CD23) expression on mononuclear phagocytes in normal and asthmatic subjects. J Immunol 1992;149: 2823-2829.
23. Leiferman KM, Ackerman SJ, Sampson HA, et al. Dermal deposition of eosinophil granule major basic protein in atopic dermatitis: comparison with onchocerciasis. N Engl J Med 1985; 313:282-285.
24. h2-like lymphokines by human T lymphocytes. Eur J Immunol 1992;22:2173-2176.
25. Demeure CE, Wu CY, Shu U, et al. In vitro maturation of human neonatal CD4 T lymphocytes: II. Cytokines present at priming modulate the development of lymphokine production. J Immunol 1994;152:4775-4782.
26. Swain SL, Huston G, Tonkonogy S, Weinberg A. Transforming growth factor-β and IL-4 cause helper T cell precursors to develop into distinct effector helper cells that differ in lymphokine secretion pattern and cell surface phenotype. J Immunol 1991;147: 2991-3000.
27. Takeuchi M, Kosiewicz MM, Alard P, Streilein JW. On the mechanisms by which transforming growth factor-beta 2 alters antigen-presenting abilities of macrophages on T cell activation. Eur J Immunol 1997;27:1648-1656.
28. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-310.
29. Kishimoto T. The biology of interleukin-6. Blood 1989;74:1-10.
30. Hirano T, Yasukawa K, Harada H, et al. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 1986;324: 73-76.
31. Muraguchi A, Hirano T, Tang B, et al. The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells. J Exp Med 1988;167:332-344.
32. Lotz M, Jirik F, Kabouridis P, et al. B cell-stimulating factor-2/interleukin 6 is a co-stimulant for human thymocytes and T lymphocytes. J Exp Med 1988;167:1253-1258.
33. Garman RD, Jacobs KA, Clark SC, Raulet DH. B cell-stimulatory factor 2 (β2 interferon) functions as a second signal for interleukin 2 production by mature murine T cells. Proc Natl Acad Sci USA 1987;84:7629-7633.
34. Vercelli D, Jabara HH, Arai KI, et al. Endogenous interleukin-6 plays an obligatory role in interleukin 4-dependent human IgE synthesis. Eur J Immunol 1989;19:1419-1424.
35. Liao SY, Liao TN, Chiang BL, et al. Decreased production of IFNγ and increased production of IL-6 by cord blood mononuclear cells of newborns with a high risk of allergy. Clin Exp Allergy 1996;26:397-405.
36. Toshitani A, Ansel JC, Chan SC, et al. Increased interleukin 6 production by T cells derived from patients with atopic dermatitis. J Invest Dermatol 1993;100:299-304.
37. Beutler B, Cerami A. Cachectin and tumor necrosis factor as two sides of the same biological coin. Nature 1986; 320:584-588.
38. Dinarello CA, Cannon JG, Wolff SM, et al. Tumor necrosis (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med 1986;163:1433-1450.
39. Beutler B, Cerami A. Cachetin: more than a tumor necrosis factor. N Engl J Med 1987;316:379-385.
40. Waage A, Brandtzaeg P, Halstensen A, et al. The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med 1989;169: 333-338.
41. Slordal L, Warren DJ, Moore AS. Effects of recombinant murine tumor necrosis factor on hempoietic reconstitution in sublethally irradiated mice. J Immunol 1989;142:833-835.
42. Grau GE, Piguet PF, Vassali P, Lambert PH. Involvement of tumor necrosis factor and other cytokines in immune-mediated vascular pathology. Int Arch Allergy Appl Immunol 1989;88: 34-39.
43. Scheurich P, Thoma B, Ucer U, Pftzenmaier K. Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-α: induction of TNF receptors on human T cells and TNF-α-mediated enhancement of T cell responses. J Immunol 1987;138: 1786-1790.
44. Kehrl JH, Miller A, Fauci AS. Effect of tumor necrosis factor-alpha on mitogen-activated human B cells. J Exp Med 1987;166:786-791.
45. Yokota T, Arai N, de Vrices JE, et al. Molecular biology of interleukin 4 and interleukin 5 genes and biology of their products that stimulate B cells, T cells and hemopoietic cells. Immunol Rev 1988;102:137-187.
46. Reinhold U, Pawelec G, Wehrmann W, et al. Cytokine release from cultured peripheral blood mononuclear cells of patients with severe atopic dermatitis. Acta Derm Venereol (Stockh) 1989;69:497-502.
47. Kapp A, Textor A, Krutmann J, Möller A. Immunomodulating cytokines in atopic dermatitis and psoriasis: production of tumor necrosis factor and lymphotoxin by mononuclear cell in vitro. Br J Dermatol 1990;122: 587-592.